IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection

Journal of Affective Disorders

Volumn 108, Issue 1-2, 2008, Pages 171-176

  Bellmann Weiler, Rosa ^a   Schroecksnadel, Katharina ^a   Holzer, Claudia ^a   Larcher, Clara ^b   Fuchs, Dietmar ^a   Weiss, Guenter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Regional Hospital   (Italy)

Author keywords

EBV; Fatigue; Interferon gamma; Tryptophan

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NEOPTERIN; TRYPTOPHAN; VIRUS CAPSID ANTIGEN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FATIGUE; FEMALE; HUMAN; IMMUNE RESPONSE; INFECTIOUS MONONUCLEOSIS; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; QUESTIONNAIRE; TH1 CELL; VIREMIA;

ADULT; ANTIGENS, VIRAL; CAPSID PROTEINS; DNA, VIRAL; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INFECTIOUS MONONUCLEOSIS; INTERFERON TYPE II; MALE; NEOPTERIN; TRYPTOPHAN; VIREMIA; VIRUS REPLICATION;

EID: 40949165212     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.09.005     Document Type: Article

References (38)

1. Adams O., Besken K., Oberdorfer C., MacKenzie C.R., Takikawa O., and Daeubner W. Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J. Virol. 78 (2004) 2632-2636
2. Bailey R.E. Diagnosis and treatment of infectious mononucleosis. Am. Fam. Phys. 49 (1994) 879-888
3. Bodaghi B., Goureau O., Zipeto D., Laurent L., Virelizier J.L., and Michelson S. Role of IFN-gamma-induced indoleamine-2,3-dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J. Immunol. 162 (1999) 957-964
4. Buchwald D., Wener M.H., Pearlman T., and Kith P. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J. Rheumatol. 24 (1997) 372-376
5. Candy B., Chalder T., Cleare A.J., Peakman A., Skowera A., Wessely S., Weinman J., Zuckerman M., and Hotopf M. Predictors of fatigue following the onset of infectious mononucleosis. Psychol. Med. 33 (2003) 847-855
6. Capuron L., and Miller A.H. Cytokines and psychopathology: lessons from interferon-α. Biol. Psychiatry 56 (2004) 819-824
7. Chan C.P., Choi J.W., Cao K.Y., Wang M., Gao Y., Zhou D.H., Di B., Xu H.F., Leung M.F., Bergmann A., Lehmann M., Nie Y.M., Cautherley G.W., Fuchs D., Renneberg R., and Zheng B.J. Detection of serum neopterin for early assessment of dengue virus infection. J. Infect. 53 (2006) 152-158
8. Cozzi A., Zignego A.L., Carpendo R., Biagiotti T., Aldinucci A., Monti M., Giannini C., Rosselli M., Laffi G., and Moroni F. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. J. Viral Hepatitis 13 (2006) 402-408
9. Fark A.R. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series. J. Fam. Pract. 32 (1991) 202-209
10. Faulstich M.E. Psychiatric aspects of AIDS. Am. J. Psychiatry 144 (1987) 551-556
11. Fuchs D., Hausen A., Reibnegger G., Werner E., Dierich M.P., and Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol. Today 9 (1988) 150-155
12. Gershburg E., and Pagano J.S. Epstein-Barr virus infections: prospects for treatment. J. Antimicrob. Chemother. 56 (2005) 277-281
13. Griffin D.E., Ward B.J., Jauregui E., Johnson R.T., and Vaisberg A. Immune activation during measles: interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J. Infect. Dis. 161 (1990) 449-453
14. Huang A., Fuchs D., Widner B., Glover C., Henderson D.C., and Allen-Mersh T.G. Tryptophan and quality of life in colorectal cancer. Adv. Exp. Med. Biol. 527 (2003) 353-358
15. Jia H., Uphold C.R., Wu S., Reid K., Findley K., and Duncan P.W. Health-related quality of life among men with HIV infection: effects of social support, coping, and depression. AIDS Patient Care STDS 18 (2004) 594-603
16. Kern P., Rokos H., and Dietrich M. Raised serum neopterin levels and imbalances of T-lymphocyte subsets in viral diseases, acquired immune deficiency and related lymphadenopathy syndromes. Biomed. Pharmacother. 38 (1984) 407-411
17. Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?. Rev. Med. Virol. 16 (2006) 251-261
18. Linde A., Andersson B., Svenson S.B., Ahrne H., Carlsson M., Forsberg P., Hugo H., Karstorp A., Lenkei R., Lindwall A., Loftenius A., Säll C., and Andersson J. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J. Infect. Dis. 165 (1992) 994-1000
19. Maia D.M., and Peace-Brewer A.L. Chronic active Epstein-Barr virus infection. Curr. Opin. Hematol. 7 (2000) 59-63
20. Murr C., Widner B., Sperner-Unterweger B., Ledochowski M., Schubert C., and Fuchs D. Immune reaction links disease progression in cancer patients with depression. Med. Hypotheses 55 (2000) 137-140
21. Obojes K., Andres O., Kim K.S., Daeubner W., and Schneider-Schaulies J. Indoleamine-2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J. Virol. 79 (2005) 7768-7776
22. Ohga S., Nomura A., Takada H., and Hara T. Immunological aspects of Epstein-Barr virus infection. Crit. Rev. Oncol./Hematol. 44 (2002) 203-215
23. Okano M., Kawa K., Kimura H., Yachie A., Wakiguchi H., Maeda A., Imai S., Ohga S., Kanegane H., Tsuchiya S., Morio T., Mori M., Yokota S., and Imashuku S. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am. J. Hematol. 80 (2005) 64-69
24. Pertovaara M., Raitala A., Uusitalo H., Pukander J., Helin H., Oja S.S., and Hurme M. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjogren's syndrome. Clin. Exp. Immunol. 142 (2005) 155-161
25. Petersen I., Thomas J.M., Hamilton W.T., and White P.D. Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort. Q. J. Math. 99 (2006) 49-55
26. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809
27. Schennach H., Meyersbach P., Schönitzer D., and Fuchs D. Additional neopterin screening to improve safety of blood donations. Pteridines 11 (2000) 76-80
28. Schroecksnadel K., Zangerle R., Bellmann-Weiler R., Garimorth K., Weiss G., and Fuchs D. Indoleamine-2,3-dioxygenase and other interferon-γ-mediated pathways in patients with human immunodeficiency virus infection. Curr. Drug Metab. 8 (2007) 225-236
29. Schuster V., Herold M., Wachter H., and Reibnegger G. Serum concentrations of interferon gamma, interleukin-6 and neopterin in patients with infectious mononucleosis and other Epstein-Barr virus-related lymphoproliferative diseases. Infection 21 (1993) 210-213
30. Shao J.Y., Li Y.H., Gao H.Y., Wu Q.L., Cui N.J., Zhang L., Cheng G., Hu L.F., Ernberg I., and Zeng Y.X. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer 100 (2004) 1162-1170
31. Swain M.G. Fatigue in chronic disease. Clin. Sci. 99 (2000) 1-8
32. Togue C., Agawa H., Sairenji T., and Inoue Y. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis. Arch. Virol. 151 (2006) 895-903
33. Werner-Felmayer G., Werner E.R., Fuchs D., Hausen A., Reibnegger G., and Wachter H. Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Cancer Res. 50 (1990) 2863-2867
34. White P., Thomas J., Kangro H., Bruce-Jones W., Amess J., Crawford D., Grover S., and Clare A. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet 358 (2001) 1946-1954
35. Widner B., Werner E.R., Schennach H., Wachter H., and Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 43 (1997) 2424-2426
36. Widner B., Laich A., Sperner-Unterweger B., Ledochowski M., and Fuchs D. Neopterin production, tryptophan degradation, and mental depression-what is the link?. Brain Behav. Immun. 16 (2002) 590-595
37. Yoshida R., Imanishi J., Oku T., Kishida T., and Hayaishi O. Induction of pulmonary indoleamine-2,3-dioxygenase by interferon. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 129-132
38. Zaknun D., Weiss G., Glatzl J., Wachter H., and Fuchs D. Neopterin levels during acute rubella in children. Clin. Infect. Dis. 17 (1993) 521-522